The 20 clinical outcomes among 14 studies that utilized individual pharmacy databases include blood pressure control in hypertension [33], fetal hemoglobin in sickle cell disease (SCD) [54], glycemic control in T1DM [40,44], vertical height in patients on growth hormones [46], and disease severity in cystic fibrosis (CF) [51]. The gene discussed is GH1; the disease is sickle cell disease.